Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
UNIVERSITE DE VERSAILLES ST QUENTIN EN YVELINES currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to ZARA, JANE J, who is the busiest examiner for the portfolio with 1 pending office action. The portfolio's current activity is limited to 1 distinct examiner and 1 distinct art unit. With 1 pending office action total, the university's current prosecution footprint is minimal.
The fact that ZARA, JANE J is the only examiner involved allows for a focused prosecution strategy that addresses the specific requirements of a single art unit. This structure suggests that the institution is not currently managing a high volume of simultaneous patent reviews in this technology area. This allows the applicant to focus its resources on resolving the specific issues raised in the Biotechnology & Pharmaceuticals sector. Practitioners should leverage this centralized workload to build a strong case for patentability with the assigned examiner. The outcome of this single matter will significantly impact the university's patent protection in its core research area. By dedicating all resources to this one case, the institution can ensure a high-quality response that addresses all examiner concerns. This focused approach is ideal for securing critical intellectual property rights with minimal administrative overhead.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZARA, JANE J | 1 | 71.0% | +16.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18266034 | SUBSTANCES AND METHODS FOR TREATING DYSTROPHIC EPIDERMOLYSIS BULLOSA | ZARA, JANE J | 21d |
| Art Unit | Apps |
|---|---|
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18266034 | SUBSTANCES AND METHODS FOR TREATING DYSTROPHIC EPIDERMOLYSIS BULLOSA | ZARA, JANE J | 1637 | §112 | Final Rejection | 21d | Pending | Jun 08, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial